Skip to search formSkip to main contentSkip to account menu

Honey bee venom

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Melittin, an amphipathic 26-residue peptide, is the main component of honey bee venom. Studies have been demonstrated that… 
Highly Cited
2012
Highly Cited
2012
Background: Diabetes is an important disease. This disease is a metabolic disorder characterized by hyperglycemia resulting from… 
Review
2002
Review
2002
Hymenoptera venoms, instead of the previously used whole body extracts, were introduced in the late 1970s for the diagnosis and… 
Highly Cited
1997
Highly Cited
1997
Background In diagnosis of type I allergy recombinant allergens have potential advantages over conventional allergenic extracts… 
Highly Cited
1996
Highly Cited
1992
Highly Cited
1992
In a double‐blind placebo‐controlled trial on 52 patients with bee venom allergy we studied the effect of a pretreatment with… 
Highly Cited
1988
Highly Cited
1988
Immunotherapy with hymenoptera venoms is safe and effective in most patients but treatment failures have been reported. Five… 
Highly Cited
1987
Highly Cited
1987
Phospholipase A2 (E.C. 3.1.1.4.) is a major allergen of honey bee venom. It exists in a glycosylated and an unglycosylated…